WATSON 954 (Reclipsen desogestrel 0.15 mg / ethinyl estradiol 0.03 mg)
Generic Name: desogestrel/ethinyl estradiol
Pill imprint WATSON 954 has been identified as Reclipsen desogestrel 0.15 mg / ethinyl estradiol 0.03 mg.
Reclipsen is used in the treatment of birth control; endometriosis; abnormal uterine bleeding; gonadotropin inhibition; polycystic ovary syndrome and belongs to the drug class contraceptives. Not for use in pregnancy. Reclipsen desogestrel 0.15 mg / ethinyl estradiol 0.03 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 954 (Reclipsen desogestrel 0.15 mg / ethinyl estradiol 0.03 mg)
- Generic Name:
- desogestrel/ethinyl estradiol
- desogestrel 0.15 mg / ethinyl estradiol 0.03 mg
- Prescription only
- Drug Class:
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide colloidal
D&C Yellow No. 10
FD&C Blue No. 2
Reclipsen is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...